MKMarketa Koberska

Marketa Koberska

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marketa Koberska has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clincelin: A redesigned lincosamide with enhanced intracellular accumulation and adaptive binding to resistant ribosomes

    by Gabriela Balíková Novotná, Michaela Novotná, Petr Slavík, Fanny Demay, Durga Mahor, David Řeha, Fanny Boissier, Julie Pokorná, Vladimir Vimberg, Marie Brajerová, et al.

    Lincosamides are an important class of clinically used antibiotics that inhibit translation by binding to the peptidyl transferase center of the ribosome. However, their efficacy is impaired by the widespread acquisition of genes coding for erythromycin resistance methyltransferase (Erm), which confer resistance by dimethylating adenine A2058 in the 23S ribosomal RNA. Here, we report clincelin, a novel chimeric lincosamide that retains conserved lincosamide thiooctose core and integrates structural features from two natural antibiotics—a propylated proline from lincomycin and salicylate from celesticetin—together with additional clinically validated C7 chlorination. Biochemical and cellular analyses revealed that the presence of salicylate and chlorination synergistically enhances intracellular accumulation, giving clincelin greater antibacterial activity than the parent compounds and the clinically used clindamycin. Notably, clincelin partially retains its efficacy against erm -mediated resistant pathogens, which is explained by cryo-electron microscopy showing that the salicylate moiety adopts distinct binding modes on drug-sensitive versus A2058-dimethylated Staphylococcus aureus ribosomes. Altogether, a comprehensive functional understanding of lincosamide structural modifications will enable the development of novel agents designed to overcome existing resistance.

  • Open Access

    CluSeek: Bioinformatics Tool to Identify and Analyze Gene Clusters

    by Ondrej Hrebicek, Stanislav Kadlcik, Lucie Najmanova, Jiri Janata, Jana Kamanova, Lada Hanzlikova, Marketa Koberska, Vojtech Kovarovic, Zdenek Kamenik

    Gene clusters are key structural and functional units that encode diverse phenotypes in genomes, from metabolism to pathogenesis. As genome sequencing expands, tools for systematic exploration of this growing data are increasingly needed. We present CluSeek, an open-source, Python-based platform for discovering, visualizing, and analyzing gene clusters across all GenBank data. Unlike existing tools, CluSeek does not rely on predefined cluster types or reference libraries but enables mining of any gene neighborhoods containing colocalized homologs of user-specified genes. It features an intuitive graphical interface suitable for non-bioinformaticians and is freely available at https://cluseek.com . We demonstrate the versatility of Cluseek in two distinct case studies: (i) mining of specialized metabolites, where CluSeek uncovered over 16 new classes containing the bioactivity-enhancing 4-alkyl-L-proline moiety, previously known in only three Golden Era antibiotic classes; and (ii) analysis of type III secretion systems present in Bordetella species, revealing previously unrecognized taxonomic distribution, and genetic variants, including gene multiplications and novel components with potential functional significance. Abstract Figure:


  • Open Access

    ABCF protein-mediated resistance shapes bacterial responses to antibiotics based on their type and concentration

    by Markéta Koběrská, Ludmila Veselá, Michaela Novotná, Durga Mahor, Aninda Mazumdar, Nikola Pinďáková, Pamela Omena Petravicius, Julie Pokorná, Zdeněk Kameník, Gabriela Balíková Novotná

    ABCF-ATPases are increasingly recognized as translation factors that rescue stalled ribosomes when they encounter difficult mRNA templates or are stalled by antibiotics. The latter defines antibiotic resistance ABCF (ARE ABCF) proteins, known for their role in antibiotic resistance. However, in this study, we reveal a broader role of ARE ABCFs in antibiotic-responsive regulation. Using genetic, OMICs, and biochemical approaches, we showed that ARE ABCF proteins TiaA and Are5sc in Streptomyces coelicolor use their resistance functions to modulate specialized metabolism and proteosynthesis in response to lincosamide, streptogramin A, and pleuromutilin (LS A P) antibiotics. Although under LS A P exposure, either Are5sc or TiaA is essential for activating the biosynthesis of the redox-active antimicrobial actinorhodin, these proteins exhibit distinct functions at the proteome level, defined by their resistance profiles and temporally regulated expression. Are5sc facilitates early adaptive responses by modulating the WblC regulon across a broad range of LS A P concentrations, while TiaA is induced later, specifically at higher concentrations, where it suppresses antibiotic stress responses, particularly against pleuromutilins. TiaA function thus reflects the ecological context of LS A P antibiotics as pleuromutilins are produced by fungi, whereas lincosamides/streptogramins originate from actinomycetes. Our findings demonstrate that ARE ABCF proteins, through their resistance function, act as global regulators of translation, mirroring the roles of non-ARE ABCF proteins like EttA. This highlights their broader ecological and physiological significance, extending beyond their established role in antibiotic resistance. IMPORTANCE: Bacteria adapt to diverse stimuli mainly through transcriptional changes that regulate adaptive protein factors. Here, we show that responses to protein synthesis-inhibiting antibiotics are fine-tuned by antibiotic resistance ABCF proteins at the translational level, enabling bacteria to differentiate between antibiotic classes and concentrations for a tailored response. Additionally, we have demonstrated that these proteins can specialize in conferring high-level resistance to specific antibiotics. Given their prevalence in pathogenic bacteria, antibiotic resistance ABCF (ARE ABCF) proteins may play a crucial role in resistance development, particularly against new antibiotics targeting the ribosomal catalytic center, presenting a significant challenge for antimicrobial therapy.


  • Open Access

    Molecular basis for the diversification of lincosamide biosynthesis by pyridoxal phosphate-dependent enzymes

    by Takahiro Mori, Yoshitaka Moriwaki, Kosuke Sakurada, Shuang Lyu, Stanislav Kadlcik, Jiri Janata, Aninda Mazumdar, Marketa Koberska, Tohru Terada, Zdenek Kamenik, et al.

    The biosynthesis of the lincosamide antibiotics lincomycin A and celesticetin involves the pyridoxal-5′-phosphate (PLP)-dependent enzymes LmbF and CcbF, which are responsible for bifurcation of the biosynthetic pathways. Despite recognizing the same S-glycosyl-l-cysteine structure of the substrates, LmbF catalyses thiol formation through β-elimination, whereas CcbF produces S-acetaldehyde through decarboxylation-coupled oxidative deamination. The structural basis for the diversification mechanism remains largely unexplored. Here we conduct structure–function analyses of LmbF and CcbF. X-ray crystal structures, docking and molecular dynamics simulations reveal that active-site aromatic residues play important roles in controlling the substrate binding mode and the reaction outcome. Furthermore, the reaction selectivity and oxygen-utilization of LmbF and CcbF were rationally engineered through structure- and calculation-based mutagenesis. Thus, the catalytic function of CcbF was switched to that of LmbF, and, remarkably, both LmbF and CcbF variants gained the oxidative-amidation activity to produce an unnatural S-acetamide derivative of lincosamide.


  • Open Access

    Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities

    by Rahul Deb, Marcelo D. T. Torres, Miroslav Boudný, Markéta Koběrská, Floriana Cappiello, Miroslav Popper, Kateřina Dvořáková Bendová, Martina Drabinová, Adelheid Hanáčková, Katy Jeannot, et al.

    Peptides that form transmembrane barrel-stave pores are potential alternative therapeutics for bacterial infections and cancer. However, their optimization for clinical translation is hampered by a lack of sequence-function understanding. Recently, we have de novo designed the first synthetic barrel-stave pore-forming antimicrobial peptide with an identified function of all residues. Here, we systematically mutate the peptide to improve pore-forming ability in anticipation of enhanced activity. Using computer simulations, supported by liposome leakage and atomic force microscopy experiments, we find that pore-forming ability, while critical, is not the limiting factor for improving activity in the submicromolar range. Affinity for bacterial and cancer cell membranes needs to be optimized simultaneously. Optimized peptides more effectively killed antibiotic-resistant ESKAPEE bacteria at submicromolar concentrations, showing low cytotoxicity to human cells and skin model. Peptides showed systemic anti-infective activity in a preclinical mouse model of Acinetobacter baumannii infection. We also demonstrate peptide optimization for pH-dependent antimicrobial and anticancer activity.


  • Erratum for Vimberg et al., “Ribosome-Mediated Attenuation of vga (A) Expression Is Shaped by the Antibiotic Resistance Specificity of Vga(A) Protein Variants”

    by Vladimir Vimberg, Jorunn Pauline Cavanagh, Michaela Novotna, Jakub Lenart, Bich Nguyen Thi Ngoc, Jana Vesela, Maria Pain, Marketa Koberska, Gabriela Balikova Novotna